This is a repository copy of User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines.White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/102796/ Version: Accepted Version
Article:Tong, V, Raynor, DK orcid.org/0000-0003-0306-5275 and Aslani, P (2017) User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines.
ReuseUnless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version -refer to the White Rose Research Online record for this item. Where records identify the publisher as the copyright holder, users can verify any specific terms of use on the publisher's website.
TakedownIf you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request.Page 1 of 23 User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines Abstract Background User testing evaluates written medicine information (WMI) usability by examining participant ability to find and understand information. It can also be an effective method to determine how consumers say they will act on information on an over-the-counter (OTC) label.
ObjectiveTo examine reported behaviors regarding dosage and storage as a measure of a .
Material and methods
U OTCto find and understand key points of information using a 13-item questionnaire. Consumers were required to elaborate on their behavior in regard to 2 additional questions: 1) when they would take diclofenac if they had constant back pain from 8am (dosage-related) and; 2) where they would store it in their home (storage-related). Responses were transcribed verbatim, and coded by 2 pharmacists.
ResultsAppropriate dosing for constant back pain was reported by 29 consumers. However, dosing intervals shorter than the specified 8 hours were often reported (n=19), due to adjusting intervals to accommodate up to the maximum of 8 tablets in 24 hours, desire for pain relief, and/or Page 2 of 23 pragmatic dosing (e.g. around bedtime). Only 29 consumers stated completely appropriate storage location examples (e.g. medicine cabinet).
ConclusionsConsumers may act inappropriately on OTC label information about dosage and/or storage, which could potentially adversely impact medicine use. User testing can contribute to the development of high quality WMI and help identify where label wordings are inappropriate for the health literacy levels of consumers.
Key wordsHealth literacy; user testing; drug labeling; non-pres...